Linvoseltamab (LINVO) plus bortezomib (BTZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): First results from the LINKER-MM2 trial.
Por:
Rodríguez-Otero, P, Delimpasi, S, Oriol, A, Dimopoulos, MA, Leleu, XP, Manier, S, Martinez-Chamorro, C, Chakraborty, R, Rubinstein, S, Sureda, A, Gonzalez, MS, Michot, JM, Breazna, A, Drew, J, Boyapati, A, Masinde, S, Kroog, GS, Sarkaria, SM and Martinez-Lopez, J
Publicada:
1 jun 2025
Resumen:
Filiaciones:
Manier, S:
Lille Univ Hosp, Dept Hematol, Lille, France
Chakraborty, R:
Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA
Rubinstein, S:
Univ North Carolina, Dept Hematol Oncol, Durham, NC USA
Sureda, A:
Univ Barcelona, Inst Catala Oncol LHospitalet, Clin Hematol Dept, IDIBELL, Barcelona, Spain
Gonzalez, MS:
Complejo Hosp Univ Santiago Compostela, Dept Hematol, Serv Galego Saude, Santiago De Compostela, Spain
Michot, JM:
Gustave Roussy Canc Campus, Villejuif, France
Breazna, A:
Regeneron Pharmaceut Inc, Tarrytown, NY USA
Martinez-Lopez, J:
CNIO Complutense Univ, Hosp Univ Octubre 12, Dept Hematol, Ciberonc,I 12, Madrid, Spain
Clin Univ Navarra, Dept Hematol, Pamplona, Spain
Gen Hosp Evangelismos, Dept Hematol & Bone Marrow Transplantat Unit, Athens, Greece
Inst Catala Oncol I Inst Josep Carreras Hosp Germa, Dept Hematol, Badalona, Spain
Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Athens, Greece
Univ Poitiers, CHU, Hematol, U1313,C 1082, Poitiers, France
Hosp Univ Quironsalud Madrid, Hematol Dept, Madrid, Spain
Univ Europea Madrid, Madrid, Spain
|